c.620C>T mutation in GATA4 is associated with congenital heart disease in South India

BMC Medical Genetics

Volumn 16, Issue 1, 2015, Pages

  Mattapally, Saidulu ^a   Nizamuddin, Sheikh ^c   Murthy, Kona Samba ^b   Thangaraj, Kumarasamy ^c   Banerjee, Sanjay K ^a,d  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b Innova Childrens Heart Hospital   (India)

^c CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^d Translational Health Science and Technology Institute   (India)

Author keywords

ASD; Congenital heart disease; GATA4; Mutation; South Indian patients; TOF; VSD

Indexed keywords

GENOMIC DNA; MICRORNA; TRANSCRIPTION FACTOR GATA 4; 3' UNTRANSLATED REGION; GATA4 PROTEIN, HUMAN;

5' UNTRANSLATED REGION; ARTICLE; CLINICAL EVALUATION; COMPUTER MODEL; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DNA ISOLATION; FALLOT TETRALOGY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INDIA; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PROMOTER REGION; SEQUENCE ANALYSIS; 3' UNTRANSLATED REGION; ADOLESCENT; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CHILD; COMPUTER SIMULATION; CONGENITAL HEART MALFORMATION; FEMALE; GENE FREQUENCY; GENETICS; GENOMICS; HAPLOTYPE; INFANT; MALE; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; YOUNG ADULT;

3' UNTRANSLATED REGIONS; ADOLESCENT; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; DNA MUTATIONAL ANALYSIS; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENE FREQUENCY; GENOMICS; HAPLOTYPES; HEART DEFECTS, CONGENITAL; HUMANS; INDIA; INFANT; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; MUTATION; YOUNG ADULT;

EID: 84923920296     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/s12881-015-0152-7     Document Type: Article

References (45)

1. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115(2):163-72.
2. Garg V. Insights into the genetic basis of congenital heart disease. CMLS. 2006;63(10):1141-8.
3. Ransom J, Srivastava D. The genetics of cardiac birth defects. Semin Cell Dev Biol. 2007;18(1):132-9.
4. Bruneau BG. The developmental genetics of congenital heart disease. Nature. 2008;451(7181):943-8.
5. Bentham J, Bhattacharya S. Genetic mechanisms controlling cardiovascular development. Ann N Y Acad Sci. 2008;1123:10-9.
6. Maitra M, Schluterman MK, Nichols HA, Richardson JA, Lo CW, Srivastava D, et al. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev Biol. 2009;326(2):368-77.
7. Hirayama-Yamada K, Kamisago M, Akimoto K, Aotsuka H, Nakamura Y, Tomita H, et al. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A. 2005;135(1):47.
8. Wang J, Fang M, Liu XY, Xin YF, Liu ZM, Chen XZ, et al. A novel GATA4 mutation responsible for congenital ventricular septal defects. Int J Mol Med. 2011;28(4):557-64.
9. Yang YQ, Gharibeh L, Li RG, Xin YF, Wang J, Liu ZM, et al. GATA4 loss-of-function mutations underlie familial tetralogy of fallot. Hum Mutat. 2013;34(12):1662-71.
10. Nemer G, Fadlalah F, Usta J, Nemer M, Dbaibo G, Obeid M, et al. A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum Mutat. 2006;27(3):293-4.
11. Peng T, Wang L, Zhou SF, Li X. Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease. Genetica. 2010;138(11-12):1231-40.
12. Posch MG, Perrot A, Schmitt K, Mittelhaus S, Esenwein EM, Stiller B, et al. Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects. Am J Med Genet A. 2008;146A(2):251-3.
13. Sarkozy A, Conti E, Neri C, D'Agostino R, Digilio MC, Esposito G, et al. Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet. 2005;42(2):e16.
14. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003;424(6947):443-7.
15. Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R, et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet. 2001;28(3):276-80.
16. Moskowitz IP, Kim JB, Moore ML, Wolf CM, Peterson MA, Shendure J, et al. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell. 2007;129(7):1365-76.
17. Pierpont ME, Basson CT, Benson Jr DW, Gelb BD, Giglia TM, Goldmuntz E, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115(23):3015-38.
18. Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115(23):2995-3014.
19. Zhao QM, Ma XJ, Jia B, Huang GY. Prevalence of congenital heart disease at live birth: an accurate assessment by echocardiographic screening. Acta Paediatr. 2013;102(4):397-402.
20. Okubo A, Miyoshi O, Baba K, Takagi M, Tsukamoto K, Kinoshita A, et al. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet. 2004;41(7):e97.
21. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 1998;281(5373):108-11.
22. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-900.
23. Deeparani T, Pillai MR, Elavazhagan T. Detection of MTHFR C677T and A1298C Gene Polymorphism in Congenital Heart Disease. Middle-East J Scientific Res. 2009;4(2):127-32.
24. McGregor TL, Misri A, Bartlett J, Orabona G, Friedman RD, Sexton D, et al. Consanguinity mapping of congenital heart disease in a South Indian population. PLoS One. 2010;5(4):e10286.
25. Ramegowda S, Kumar A, Savitha MR, Krishnamurthy B, Doddaiah N, Ramachandra NB. Missense mutation G296S in GATA4 is not responsible for cardiac septal defects. Indian J Human Genet. 2007;13(1):30-2.
26. Dinesh SM, Lingaiah K, Savitha MR, Krishnamurthy B, Narayanappa D, Ramachandra NB. GATA4 specific nonsynonymous single-nucleotide polymorphisms in congenital heart disease patients of Mysore, India. Genet Test Mol Biomarkers. 2011;15(10):715-20.
27. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor. New York: Cold Spring Harbor Laboratory Press; 1989.
28. Thangaraj K, Singh L, Reddy AG, Rao VR, Sehgal SC, Underhill PA, et al. Genetic affinities of the Andaman Islanders, a vanishing human population. Current Biol. 2003;13(2):86-93.
29. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-75.
30. Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR. An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet. 2006;15(16):2490-508.
31. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet. 2007;39(10):1278-84.
32. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-5.
33. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet. 2005;76(3):449-62.
34. R., Development., Core., Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011. ISBN 3-900051-07-0.
35. Srivastava D, Olson EN. A genetic blueprint for cardiac development. Nature. 2000;407(6801):221-6.
36. Pu WT, Ishiwata T, Juraszek AL, Ma Q, Izumo S. GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev Biol. 2004;275(1):235-44.
37. Reamon-Buettner SM, Borlak J. GATA4 zinc finger mutations as a molecular rationale for septation defects of the human heart. J Med Genet. 2005;42(5):e32.
38. Tomita-Mitchell A, Maslen CL, Morris CD, Garg V, Goldmuntz E. GATA4 sequence variants in patients with congenital heart disease. J Med Genet. 2007;44(12):779-83.
39. Reich D, Thangaraj K, Patterson N, Price AL, Singh L. Reconstructing Indian population history. Nature. 2009;461(7263):489-94.
40. Dhandapany PS, Sadayappan S, Xue Y, Powell GT, Rani DS, Nallari P, et al. A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat Genet. 2009;41(2):187-91.
41. Wang E, Sun S, Qiao B, Duan W, Huang G, An Y, et al. Identification of functional mutations in GATA4 in patients with congenital heart disease. PLoS One. 2013;8(4):e62138.
42. Posch MG, Perrot A, Berger F, Ozcelik C. Molecular genetics of congenital atrial septal defects. Clin Res Cardiol. 2010;99(3):137-47.
43. Reamon-Buettner SM, Cho SH, Borlak J. Mutations in the 3'-untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD). BMC Med Genet. 2007;8:38.
44. Hesketh J. 3'-Untranslated regions are important in mRNA localization and translation: lessons from selenium and metallothionein. Biochem Soc Trans. 2004;32(Pt 6):990-3.
45. Conne B, Stutz A, Vassalli JD. The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med. 2000;6(6):637-41.